Table 2.
Thermocoagulation assessment immediately after treatment and at the 1-month control visit
| Variable | N | % | ||
|---|---|---|---|---|
| Immediately after treatment | Total women treated | 110 | 90.9 | |
| Pain | ||||
| Yes | 105 | 95.5 | ||
| No | 3 | 2.7 | ||
| Not specified | 2 | 1.8 | ||
| VAS pain score (mean ± SD) | 3.0 ± 1.6 | |||
| VAS pain score (median, range) | 2 (1–8) | |||
| Desire of future pregnancy | 54 | 49.1 | ||
| At the 1-month control visit | Total women seen at the 1-month visit | 109 | 99.1 | |
| Pain | ||||
| Yes | 34 | 31.2 | ||
| No | 75 | 68.8 | ||
| VAS pain score (mean ± SD) | 0.8 ± 1.4 | |||
| Pain duration (mean ± SD), days | 2.1 ± 4.8 | |||
| Vaginal discharge | ||||
| Yes | 108 | 99.1 | ||
| No | 1 | 0.9 | ||
| Vaginal discharge duration (mean ± SD), days | 16.2 ± 8.4 | |||
| Cicatrisation | ||||
| Yes | 100 | 91.7 | ||
| No | 9 | 8.3 |